These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17428846)

  • 1. Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus.
    Katpally U; Smith TJ
    J Virol; 2007 Jun; 81(12):6307-15. PubMed ID: 17428846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
    Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
    Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human rhinovirus capsid dynamics is controlled by canyon flexibility.
    Reisdorph N; Thomas JJ; Katpally U; Chase E; Harris K; Siuzdak G; Smith TJ
    Virology; 2003 Sep; 314(1):34-44. PubMed ID: 14517058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of human rhinovirus 16.
    Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
    Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human rhinovirus 3 at 3.0 A resolution.
    Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
    Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral agent blocks breathing of the common cold virus.
    Lewis JK; Bothner B; Smith TJ; Siuzdak G
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6774-8. PubMed ID: 9618488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
    Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
    J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP4 protein from human rhinovirus 14 is released by pressure and locked in the capsid by the antiviral compound WIN.
    Gonçalves RB; Mendes YS; Soares MR; Katpally U; Smith TJ; Silva JL; Oliveira AC
    J Mol Biol; 2007 Feb; 366(1):295-306. PubMed ID: 17161425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rhinovirus type 16: mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis.
    Lee WM; Wang W
    J Virol; 2003 Jun; 77(11):6235-44. PubMed ID: 12743280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human rhinovirus 14 complexed with fragments of active antiviral compounds.
    Bibler-Muckelbauer JK; Kremer MJ; Rossmann MG; Diana GD; Dutko FJ; Pevear DC; McKinlay MA
    Virology; 1994 Jul; 202(1):360-9. PubMed ID: 8009848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus.
    Phelps DK; Post CB
    Protein Sci; 1999 Nov; 8(11):2281-9. PubMed ID: 10595531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
    Shepard DA; Heinz BA; Rueckert RR
    J Virol; 1993 Apr; 67(4):2245-54. PubMed ID: 8383239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface.
    Wang W; Lee WM; Mosser AG; Rueckert RR
    J Virol; 1998 Feb; 72(2):1210-8. PubMed ID: 9445020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel benzonitrile analogue inhibits rhinovirus replication.
    Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.
    Li Y; Zhou Z; Post CB
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7529-34. PubMed ID: 15899980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.
    Heinz BA; Rueckert RR; Shepard DA; Dutko FJ; McKinlay MA; Fancher M; Rossmann MG; Badger J; Smith TJ
    J Virol; 1989 Jun; 63(6):2476-85. PubMed ID: 2542566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.
    Zhang Y; Simpson AA; Ledford RM; Bator CM; Chakravarty S; Skochko GA; Demenczuk TM; Watanyar A; Pevear DC; Rossmann MG
    J Virol; 2004 Oct; 78(20):11061-9. PubMed ID: 15452226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulations of human rhinovirus and an antiviral compound.
    Speelman B; Brooks BR; Post CB
    Biophys J; 2001 Jan; 80(1):121-9. PubMed ID: 11159387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
    Kim KH; Willingmann P; Gong ZX; Kremer MJ; Chapman MS; Minor I; Oliveira MA; Rossmann MG; Andries K; Diana GD
    J Mol Biol; 1993 Mar; 230(1):206-27. PubMed ID: 8383771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
    Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
    Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.